Skip to main content
. 2012 Feb 16;12(2):2284–2308. doi: 10.3390/s120202284

Figure 2.

Figure 2.

Figure 2.

Schematic description of MS approaches used in biomarkers discovery. (A) SELDI-TOF; (B) SILAC.